PG
MRNA icon

Pendal Group’s Moderna MRNA Stock Holding History

Pendal Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$253K Sell
1,408
-9,768
-87% -$1.6M ﹤0.01% 456
2022
Q3 		$1.32M Buy
11,176
+7,202
+181% +$1.09M 0.01% 240
2022
Q2 		$568K Sell
3,974
-11,879
-75% -$1.7M 0.01% 334
2022
Q1 		$2.73M Buy
+15,853
New +$2.67M 0.02% 209
2021
Q3 		– Sell
-8,210
Closed -$1.93M – 628
2021
Q2 		$1.93M Buy
8,210
+3,784
+85% +$676K 0.02% 245
2021
Q1 		$580K Buy
+4,426
New +$641K 0.01% 387

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pendal Group's MRNA Position: Q4 2022 in Review

Pendal Group reduced its Moderna (MRNA) stake by 87% in Q4 2022, selling an estimated $1.6M and leaving 1,408 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #456.

Pendal Group first reported a position in MRNA in Q1 2021 and has held it in 6 quarters since. The position peaked at $2.73M in Q1 2022. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Pendal Group held 1,408 shares of Moderna worth $253K as of Q4 2022.
  • Pendal Group sold 9,768 Moderna shares in Q4 2022, an estimated $1.6M.
  • Moderna made up ﹤0.01% of Pendal Group's portfolio in Q4 2022, its #456 holding.
  • Pendal Group first reported a position in Moderna in Q1 2021 and has held it in 6 quarters since.
  • Pendal Group's Moderna position peaked at $2.73M in Q1 2022.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.